Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Jan;21(1):71–74. doi: 10.1111/j.1365-2125.1986.tb02824.x

Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose.

L E Domino, S E Domino, M S Stockstill
PMCID: PMC1400798  PMID: 3947506

Abstract

The time course of toxicity in a 28 year old man following a 100 mg accidental overdose of clonidine hydrochloride is compared with the decline of plasma clonidine over 5 days. The concentration data were analyzed by nonlinear least squares regression, and fitted to a model which dissociated the blood pressure effects into pressor and depressor components. According to this analysis, there appeared to be two phases of toxicity over time--a hypertensive, and a hypotensive phase. The hypotensive and the hypertensive phases may result primarily through differential stimulation of central alpha 2-, alpha 1-, and vascular post-synaptic alpha 2-adrenoceptors as plasma concentrations fall.

Full text

PDF
71

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arndts D., Stähle H., Struck C. J. A newly developed precise and sensitive radioimmunoassay for clonidine. Arzneimittelforschung. 1979;29(3):532–538. [PubMed] [Google Scholar]
  2. Boxenbaum H. G., Riegelman S., Elashoff R. M. Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm. 1974 Apr;2(2):123–148. doi: 10.1007/BF01061504. [DOI] [PubMed] [Google Scholar]
  3. Conner C. S., Watanabe A. S. Clonidine overdose: a review. Am J Hosp Pharm. 1979 Jul;36(7):906–911. [PubMed] [Google Scholar]
  4. Frisk-Holmberg M., Paalzow L., Wibell L. Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man. Eur J Clin Pharmacol. 1984;26(3):309–313. doi: 10.1007/BF00548760. [DOI] [PubMed] [Google Scholar]
  5. Kobinger Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol. 1978;81:39–100. doi: 10.1007/BFb0034091. [DOI] [PubMed] [Google Scholar]
  6. Paalzow L. K., Edlund P. O. Multiple receptor responses: a new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: studies on clonidine in the rat and cat. J Pharmacokinet Biopharm. 1979 Oct;7(5):495–510. doi: 10.1007/BF01062391. [DOI] [PubMed] [Google Scholar]
  7. Reid J. L., Wing L. M., Dargie H. J., Hamilton C. A., Davies D. S., Dollery C. T. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet. 1977 Jun 4;1(8023):1171–1174. doi: 10.1016/s0140-6736(77)92715-5. [DOI] [PubMed] [Google Scholar]
  8. Wing L. M., Reid J. L., Davies D. S., Dargie H. J., Dollery C. T. Apparent resistance to hypotensive effect of clonidine. Br Med J. 1977 Jan 15;1(6054):136–138. doi: 10.1136/bmj.1.6054.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wing L. M., Reid J. L., Davies D. S., Neill E. A., Tippett P., Dollery C. T. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension. Eur J Clin Pharmacol. 1977 Dec 28;12(6):463–469. doi: 10.1007/BF00561067. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES